Sumitomo Mitsui Trust Group Inc. Sells 2,015,230 Shares of Healthpeak Properties, Inc. (NYSE:DOC)

Sumitomo Mitsui Trust Group Inc. trimmed its position in Healthpeak Properties, Inc. (NYSE:DOC) by 44.9% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,471,651 shares of the real estate investment trust’s stock after selling 2,015,230 shares during the period. Sumitomo Mitsui Trust Group Inc. owned 0.35% of Healthpeak Properties worth $50,100,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. HM Payson & Co. purchased a new stake in shares of Healthpeak Properties in the third quarter worth $25,000. S.A. Mason LLC bought a new position in Healthpeak Properties in the 3rd quarter worth about $26,000. Rise Advisors LLC purchased a new stake in shares of Healthpeak Properties in the 3rd quarter valued at about $29,000. Fortitude Family Office LLC bought a new stake in shares of Healthpeak Properties during the 3rd quarter valued at about $32,000. Finally, Barrett & Company Inc. bought a new stake in shares of Healthpeak Properties during the 3rd quarter valued at about $33,000. 93.57% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on the stock. Royal Bank of Canada raised their target price on shares of Healthpeak Properties from $25.00 to $26.00 and gave the company an “outperform” rating in a research note on Monday, November 4th. StockNews.com cut shares of Healthpeak Properties from a “hold” rating to a “sell” rating in a research report on Wednesday, October 30th. Morgan Stanley raised shares of Healthpeak Properties from an “equal weight” rating to an “overweight” rating and set a $25.00 price objective for the company in a report on Wednesday, January 15th. Robert W. Baird increased their target price on Healthpeak Properties from $24.00 to $25.00 and gave the company an “outperform” rating in a research note on Wednesday, October 30th. Finally, Mizuho dropped their price target on Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating for the company in a research note on Thursday, December 5th. One analyst has rated the stock with a sell rating, three have assigned a hold rating, ten have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, Healthpeak Properties has an average rating of “Moderate Buy” and an average target price of $24.15.

Healthpeak Properties Price Performance

Shares of Healthpeak Properties stock opened at $19.58 on Tuesday. The company has a debt-to-equity ratio of 0.96, a current ratio of 1.35 and a quick ratio of 1.31. Healthpeak Properties, Inc. has a one year low of $16.01 and a one year high of $23.26. The business’s 50 day simple moving average is $20.54 and its two-hundred day simple moving average is $21.52. The stock has a market capitalization of $13.70 billion, a P/E ratio of 55.94, a price-to-earnings-growth ratio of 2.18 and a beta of 1.15.

Healthpeak Properties Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, February 26th. Investors of record on Friday, February 14th will be paid a $0.305 dividend. This represents a $1.22 annualized dividend and a dividend yield of 6.23%. This is an increase from Healthpeak Properties’s previous quarterly dividend of $0.30. The ex-dividend date is Friday, February 14th. Healthpeak Properties’s payout ratio is presently 342.87%.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.